Key result
High mean platelet volume (>9.9 fl) in NSTE-ACS patients independently predicted 12-month major cardiac outcomes compared to lower MPV (HR 1.52; 95% CI 1.01-2.29; P=0.04).
Why the study?
Is high mean platelet volume associated with increased culprit lesion severity and major cardiac outcomes in patients with NSTE-ACS?
Population
344 patients with acute coronary syndrome with non-ST elevation who had significant coronary stenosis at…
Comparison
High mean platelet volume vs Low mean platelet volume
Design
Cohort
Follow-up
12 months
Authors
Loading...
High MPV may aid NSTE-ACS risk stratification; leaves open incremental value and need for prospective validation.
Cohort (n=344)
Is high mean platelet volume associated with increased culprit lesion severity and major cardiac outcomes in patients with NSTE-ACS?
Effect estimate: HR 1.52 (95% CI 1.01-2.29)
Absolute Event Rate: 39% vs 26%
p-value: p=0.04
Elevated mean platelet volume (>9.9 fl) on admission is an independent predictor of severe culprit stenosis and 12-month major cardiac outcomes in patients with NSTE-ACS.
Doğan et al. (2012) conducted a cohort in Acute coronary syndrome with non-ST elevation (NSTE-ACS) (n=344). High mean platelet volume (>9.9 fl) vs. Low mean platelet volume (≤ 9.9 fl) was evaluated on Composite of cardiac death, myocardial infarction, recurrent angina or hospitalization (HR 1.52, 95% CI 1.01-2.29, p=0.04). High mean platelet volume (>9.9 fl) in NSTE-ACS patients independently predicted 12-month major cardiac outcomes compared to lower MPV (HR 1.52; 95% CI 1.01-2.29; P=0.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: